Acasti Pharma reported CAD258M in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acasti Pharma ACST:US C$ 258M 60.8M
Addus Homecare ADUS:US $ 0.02M 0M
Agile Therapeutics AGRX:US $ 0.01M 0M
Amarin AMRN:US $ 293.14M 0.36M
Bioscrip BIOS:US $ 0.02M 0M
Genetic Technologies GENE:US $ 153.57M 6.51M
Pain Therapeutics PTIE:US $ 460.7M 0.65M